The Effect of Cold Spray and Ice Applied During Intravenous Access on Pain and Fear i in Pediatric Emergency Unit

October 30, 2023 updated by: Duygu Sonmez Duzkaya, Tarsus University

The Effect of Cold Spray and Ice Applied During Intravenous Access on Pain and Fear in Children Aged 7-15 Years in Pediatric Emergency Unit

Many strategies have been developed for the prevention of to prevent procedural pain in pediatric emergency units where nurses play a vital role in patient comfort.Easy-to-use and inexpensive nonpharmacologic analgesic methods are important in emergency units.This study was conducted to determine the effect of cold spray and ice applied during venipuncture on the level of fear and pain in children ages 7-15. This randomized, controlled experimental study was conducted in the Pediatric Emergency Clinic of Istanbul Gaziosmanpaşa Training and Research Hospital between November 2021 7 and April 2022. The study was conducted with 96 children between the ages of 7 and 15 (cold spray group, ice group, and control group) who were scheduled to have venous access in the pediatric emergency clinic and met the sampling criteria.

The Pediatric Emergency Clinic consists of 10 beds. Patients with complaints such as fever, vomiting, diarrhea, and seizures comprise the majority of those admitted to the clinic. In the Pediatric Emergency Clinic, intravenous interventions were performed in the injection room.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aimed to determine the effect of cold spray and ice applied during venipuncture procedures on pain and fear in 67 children ages 7-15 admitted to the pediatric emergency unit.

Materials and Methods Setting This randomized, controlled experimental study was conducted in the Pediatric Emergency Clinic of Istanbul Gaziosmanpaşa Training and Research Hospital between November 2021 7 and April 2022. The Pediatric Emergency Clinic consists of 10 beds. Patients with complaints such as fever, vomiting, diarrhea, and seizures comprise the majority of those admitted to the clinic. In the Pediatric Emergency Clinic, intravenous interventions were performed in the injection room.

Sample The study's population comprised children ages 7-15 treated in the Pediatric Emergency Department of Gaziosmanpaşa Training and Research Hospital. The sample consisted of children undergoing intravenous access in line with the inclusion criteria. According to the power analysis for the sample size in line with the literatüre the power of the sample was calculated with the G*Power 3.1 program. With a Type I error of 0.05 and a test power of 0.80 (α= 0.05, 1-β= 0.80), the minimum sample size was calculated as children (30 children in 83 each group). The study was completed with 96 children, including 32 children in the study and control groups, taking into account the losses that might occur from the sample for any reason during the study period.

Allocation In the study, 96 children in the sample will randomly assigned to the control (n=32), ice (n=32), and spray groups (n=32). Random assignment will ensured by using a computer program to determine the group of children (https://www.randomlists.com/team-generator).

Data Collection Before starting the study, the families of the children were informed of the purpose, plan, duration, and how the data would be used. Written consent was obtained in light of the principle of willingness and voluntariness through the Voluntary Information and Consent Form. Pediatric patients included in the study were divided into three groups: cold spray, ice, and control. Environmental conditions were organized the same way in all three groups, and at least one parent was ensured to stay with each child. The study was conducted with a nurse performing intravenous intervention and a nurse researcher.

IV Catheter placement IV placement was performed using 24-gauge catheters appropriate in size for the age of the children and took an average of 3 minutes. The observer nurse evaluated the children in all groups before and after the procedure by filling out the data collection form and measuring the child's pain and fear assessment scales. The pain and fear scales were also evaluated by the child and parent. In all groups, IV insertion was performed by the same nurse following the procedure steps.

  • First study group: Before performing intravenous intervention, cold spray was applied for 5 seconds at a distance of 15 cm to an area of approximately 5 cm2 at the site of the procedure. After tourniquet fixation and subsequent skin disinfection for 60 seconds, the nurse researcher performed intravenous administration.
  • Second study group: Before the intravenous intervention, refrigerated gel ice was applied for 5 minutes at 2 cm above the area to be treated. After that, the nurse removed the gel ice from the procedure area, a tourniquet was applied, and skin disinfection was performed for 60 seconds. The nurse researcher performed intravenous administration.
  • Control group: No pharmacologic or nonpharmacologic application was performed. The researcher performed intravenous access after skin disinfection by the nurse.

ETHICAL CONSIDERATION Written permission were obtained from the ethics committee of Gaizosmanpaşa Training and Research Hospital to collect the data before the study (No: 347, Date: 20.10.2021). The rules of the Declaration of Helsinki were followed throughout the study. Verbal and written informed consent was obtained from the families of pediatric patients who agreed to participate in the study. After patients entered the pediatric emergency clinic in accordance with the sample selection criteria, the parents were explained the purpose of the research, that their personal information would remain confidential, and that their privacy would be respected.

STATISTICAL ANALYSIS Statistical analyses were performed using R vers. 2.15.3 program Minimum, maximum, mean, standard deviation, median, first quartile, third quartile, frequency, and percentage were used to report the study data. The Shapiro-Wilk test and graphical analysis were used to evaluate the compliance of quantitative data with normal distribution. A dependent groups t-test was used to compare the values before and after the intervention. An independent groups t-test was used to evaluate normally distributed variables between two groups. One-way analysis of variance was used in the evaluations of variables with normal distribution between more than two groups. The Mann-Whitney U test evaluated variables that did not show normal distribution between the two groups. The Kruskal-Wallis test was used in the evaluations of variables that did not show normal distribution between more than two groups. Pearson correlation analysis was used to determine the relationship between quantitative variables. The Pearson chi-square test, Fisher-Freeman-Halton exact test, and Fisher's exact test were used to compare qualitative variables. Statistical significance was accepted as p<0.05.

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Mersin, Turkey, 33400
        • Tarsus University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children included in the study were 7-15 years old
  • volunteered to participate
  • Had no chronic diseases, mental or neurological disabilities, neurodevelopmental impairments, or life threatening conditions (sepsis, shock, respiratory/cardiogenic arrest, etc.).

Exclusion Criteria:

  • Children who had taken any analgesic medication before presentation to the emergency department
  • had undergone multiple attempts for vascular access

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: First study group
Before performing intravenous intervention, cold spray was applied for 5 seconds at a distance of 15 cm to an area of approximately 5 cm2 at the site of the procedure. After tourniquet fixation and subsequent skin disinfection for 60 seconds, the nurse researcher performed intravenous administration.
Other: Cold spray
Cold spray was applied for 5 seconds at a distance of 15 cm to an area of approximately 5 cm2 at the site of the procedu
Experimental: Second study group
Before the intravenous intervention, refrigerated gel ice was applied for 5 minutes at 2 cm above the area to be treated. After that, the nurse removed the gel ice from the procedure area, a tourniquet was applied, and skin disinfection was performed for 60 seconds. The nurse researcher performed intravenous administration.
Other: Refrigerated gel ice
Refrigerated gel ice was applied for 5 minutes at 2 cm above the area to be treated.
No Intervention: Control group
No pharmacologic or nonpharmacologic application was performed. The researcher performed intravenous access after skin disinfection by the nurse.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Data Collection Form
Time Frame: 1 day
The data collection form was prepared by reviewing the literature on the subject. It consisted of a total of 15 questions, including questions about the child's and family's descriptive characteristics (such as age and gender), the reason for going to the emergency room, and complaints, such as previous emergency room visits
1 day
Child Fear Scale
Time Frame: 1 day
The Child Fear Scale is used to assess the anxiety levels of children with five face shapes scored between 0-4: 0 = no anxiety, and 4 = severe anxiety. The scale can be evaluated by both the child and the researcher before, during, and after the intervention.
1 day
Visual Analog Scale
Time Frame: 1 day
The VAS is the most frequently used scale in pain studies. In children over 7 years of age, it is frequently used because it is common and easy. The VAS is a pain scale with numbers from 1 to 10, equally spaced on a 10 cm horizontal ruler. Children being assessed are asked to choose a pain value between 1 and 10 on this ruler.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tarsus University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Actual)

April 15, 2022

Study Completion (Actual)

April 15, 2022

Study Registration Dates

First Submitted

October 24, 2023

First Submitted That Met QC Criteria

October 30, 2023

First Posted (Actual)

October 31, 2023

Study Record Updates

Last Update Posted (Actual)

October 31, 2023

Last Update Submitted That Met QC Criteria

October 30, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 347

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Cold spray

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe